article · Frontiers in Cellular and Infection Microbiology
Introduction Cigarette smoke is a major risk factor for respiratory infections and chronic inflammatory lung diseases, yet the mechanisms through which it alters host–pathogen interactions remain incompletely understood. Klebsiella pneumoniae is an opportunistic Gram-negative pathogen that causes severe infections, particularly in susceptible individuals. This study investigated the effects of cigarette smoke extract (CSE) on K. pneumoniae virulence-associated traits and host immune responses. Methods Three multidrug-resistant, extended-spectrum β-lactamase-producing clinical K. pneumoniae isolates were exposed to CSE. Bacterial growth, virulence gene expression ( mrkA, luxS , and AcrB ), biofilm formation, antimicrobial susceptibility, macrophage invasion, neutrophil phagocytosis, and cytokine responses in THP-1-derived macrophages were evaluated using microbiological, molecular, and cell culture assays. Results High concentrations of CSE (≥25%) suppressed bacterial growth, whereas 5–10% CSE had minimal effects. Exposure to 10% CSE significantly upregulated mrkA, luxS , and AcrB expression. Biofilm formation increased by 20.8–37.0%, and minimum inhibitory concentrations of ciprofloxacin and tigecycline increased two-fold following CSE exposure. CSE enhanced bacterial invasion of THP-1 macrophages and impaired neutrophil phagocytosis, reducing bacterial uptake by 17.8% and 29.9% after 30 and 60 min, respectively. Furthermore, CSE promoted a pro-inflammatory response characterized by increased TNF-α and IL-1β expression and reduced IL-10 expression across multiple time points. Discussion CSE enhances the virulence potential of K. pneumoniae while disrupting innate immune defenses and immune regulation. These findings demonstrate a harmful synergy between cigarette smoke and bacterial infection that may contribute to the increased susceptibility and severity of respiratory infections observed in smokers.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/fcimb.2026.1787424
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.